颅骨安装Smartframe装置用于H3K27胶质瘤活检与消融:技术病例报告
本文报告一例颅骨安装Clearpoint Smartframe装置用于H3K27胶质瘤活检与消融的技术案例。患者为右侧第四脑室旁亚厘米级强化病灶伴脑积水,首次经枕部穿刺活检无诊断结果,二次手术通过前次分离空间将框架直接安装于颅骨,完成诊断性活检及立体定向激光消融。
要点
- 颅骨安装Smartframe可用于中线病灶的活检与激光消融。
- 前次手术分离的空间可为框架颅骨安装提供条件。
- 亚厘米级病灶首次活检可能无诊断结果,需再次活检。
核心结论
- 颅骨安装Clearpoint Smartframe装置可用于中线H3K27胶质瘤的活检与消融。
研究设计与样本
- 技术病例报告,描述一例颅骨安装Clearpoint Smartframe手术的临床情境与操作。
主要发现
- 患者右侧第四脑室旁亚厘米级强化病灶伴脑积水,首次经枕部穿刺活检无诊断结果。
- 二次手术将Smartframe经前次手术分离空间安装于颅骨,完成诊断性活检(H3K27胶质瘤)及立体定向激光消融。
临床怎么用
- 对于需活检的中线小病灶,可考虑颅骨安装Smartframe进行立体定向活检与激光消融。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clearpoint Smartframe is a magnetic resonance imaging-compatible stereotactic system often used to perform magnetic resonance imaging-guided biopsies. The system is typically mounted on the scalp through screws that pierce the skin and penetrate the outer table of the cranium. However, the frame can also be configured to be mounted directly onto the skull. CASE DESCRIPTION: Here, we describe the clinical context well suited for a skull-mount Clearpoint Smartframe surgery. The patient suffered from a subcentimeter right parafourth ventricular contrast-enhancing lesion with hydrocephalus and underwent a right suboccipital needle biopsy followed by an occipital ventriculoperitoneal shunt. Although the hydrocephalus resolved with the ventriculoperitoneal shunt, the biopsy sample proved nondiagnostic. The patient underwent a second procedure during which the Clearpoint Smartframe was mounted onto the skull through space dissected free during the previous surgery. Diagnostic biopsy (H3K27 glioma) was performed followed by stereotactic laser ablation of the lesion. CONCLUSIONS: We describe a case in which the skull mount Clearpoint Smartframe was used to biopsy and ablate a midline H3K27 glioma.
引用
- Bartek J, Alattar A, Jensdottir M, et al. Biopsy and Ablation of H3K27 Glioma Using Skull-Mounted Smartframe Device: Technical Case Report. World Neurosurg. 2019. PMID: 30974271. doi:10.1016/j.wneu.2019.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。